‘Israel Presented Syria With Proposal For New Security Agreement’ – Axios

https://www.axios.com/2025/09/16/israel-syria-security-agreement-dermer

byBenzinga Newsdesk

September 16, 2025

1 minute read

https://www.axios.com/2025/09/16/israel-syria-security-agreement-dermer

Telsey Advisory Group Maintains Market Perform on Big Lots, Lowers Price Target to $30

By Benzinga Newsdesk

May 31, 10:13 AM

Telsey Advisory Group analyst Dana Telsey maintains Big Lots (NYSE:BIG) with a Market Perform and lowers the price target from $32 to $30.

BIG

News

Bally’s Releases Round 2 Predictor Game To Delight College Hoops Prize Seekers

By Benzinga Newsdesk

March 28, 7:33 AM

Bally's Interactive, the digital gaming unit of Bally's Corporation (NYSE:BALY), today unveiled 'Bally Bracket: $100K Overtime,' a free-to-play game that allows fans to make predictions on the final two

BALY

Susquehanna Maintains Positive on NVIDIA, Raises Price Target to $250

By vishwanath@benzinga.com

September 28, 7:15 AM

Susquehanna analyst Christopher Rolland maintains NVIDIA (NASDAQ:NVDA) with a Positive and raises the price target from $220 to $250.

NVDA

Karyopharm Announces New Interim Phase 2 Selinexor Data In Myelofibrosis Selected For Oral Presentation At American Society Of Hematology 2021 Annual Meeting And Exposition

By Benzinga Newsdesk

November 4, 10:31 AM

Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that an abstract detailing new data from a Phase 2 study evaluating selinexor, a

KPTI

‘Israel Presented Syria With Proposal For New Security Agreement’ – Axios

Related Posts

Telsey Advisory Group Maintains Market Perform on Big Lots, Lowers Price Target to $30

Bally’s Releases Round 2 Predictor Game To Delight College Hoops Prize Seekers

Susquehanna Maintains Positive on NVIDIA, Raises Price Target to $250

Karyopharm Announces New Interim Phase 2 Selinexor Data In Myelofibrosis Selected For Oral Presentation At American Society Of Hematology 2021 Annual Meeting And Exposition